Ophthalmology · Chula Vista, CA
NPI
1023357670
Since 2013
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
835 Third Ave Ste A
Chula Vista, CA, 91911
Phone (619) 425-7755
Groups this clinician bills Medicare through
Medicare paid, 2024
$276K
4,941 services
Medicare patients, 2024
782
Average age 74
Drug cost, 2024
$107K
1,501 prescriptions
Company payments, 2025
$678
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emma C McDonnell was code J0585 (injection, onabotulinumtoxina, 1 unit), 2,900 times for 24 patients. In total Emma C McDonnell billed 4,941 services in 57 codes, and Medicare paid $276K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 2,900 | 24 | $4.89 | $14K |
| 92012 Ophthalmological E&M | Office | 611 | 494 | $65.81 | $40K |
| 92285 Standard X-ray | Office | 520 | 477 | $18.08 | $9,400 |
| 99214 Office E&M - Established | Office | 205 | 192 | $94.40 | $19K |
| 15823 Skin | Facility | 124 | 124 | $709.20 | $88K |
| 99213 Office E&M - Established | Office | 96 | 93 | $68.35 | $6,562 |
| 64612 Musculoskeletal | Office | 55 | 24 | $115.82 | $6,370 |
| 67903 Eye | Facility | 40 | 39 | $556.57 | $22K |
| 67840 Eye | Office | 38 | 37 | $224.41 | $8,527 |
| 92083 Vision, Hearing, and Speech Services | Office | 31 | 30 | $50.05 | $1,552 |
| 92014 Ophthalmological E&M | Office | 30 | 29 | $97.52 | $2,926 |
| 67917 Eye | Facility | 27 | 25 | $347.66 | $9,387 |
| 68801 Eye | Office | 23 | 22 | $102.36 | $2,354 |
| 99204 Office E&M - New | Office | 23 | 23 | $96.56 | $2,221 |
| 92004 Ophthalmological E&M | Office | 18 | 18 | $86.74 | $1,561 |
By year: 2022 $284K for 2,203 services; 2023 $327K for 4,094 services; 2024 $276K for 4,941 services.
Medicare prescription drug claims, 2024
In 2024, the drug Emma C McDonnell prescribed most often to Medicare patients was Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha), with 717 prescriptions and refills. In total Emma C McDonnell wrote 1,501 Medicare prescriptions that cost $107K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 717 | 734 | 479 | $8,163 |
| Erythromycin Erythromycin Base | 353 | 358 | 176 | $3,777 |
| Cyclosporine Generic | 98 | 138 | 24 | $35K |
| Restasis Cyclosporine | 41 | 53 | 14 | $29K |
| Doxycycline Hyclate Generic | 33 | 33 | 23 | $555 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 30 | 30 | 23 | $207 |
| Latanoprost Generic | 26 | 42 | Under 11 | $148 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 24 | 24 | 18 | $897 |
| Brimonidine Tartrate Generic | 16 | 20 | Under 11 | $268 |
| Moxifloxacin Moxifloxacin Hcl | 15 | 15 | Under 11 | $254 |
| Xiidra Lifitegrast | 13 | 23 | Under 11 | $15K |
| Fluorometholone Generic | 11 | 16 | Under 11 | $841 |
Brand drugs: 674 claims; generic drugs: 827 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emma C McDonnell $678 ($678 in general payments such as food, travel and fees) from 7 companies. The largest payer was Sight Sciences, Inc. with $443.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.